JP2020502498A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502498A5 JP2020502498A5 JP2019528092A JP2019528092A JP2020502498A5 JP 2020502498 A5 JP2020502498 A5 JP 2020502498A5 JP 2019528092 A JP2019528092 A JP 2019528092A JP 2019528092 A JP2019528092 A JP 2019528092A JP 2020502498 A5 JP2020502498 A5 JP 2020502498A5
- Authority
- JP
- Japan
- Prior art keywords
- protein encoded
- group
- gene selected
- tubb3
- hmga2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16306561 | 2016-11-25 | ||
| EP16306561.8 | 2016-11-25 | ||
| PCT/EP2017/080414 WO2018096117A1 (en) | 2016-11-25 | 2017-11-24 | New biomarkers of human skin aging |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020502498A JP2020502498A (ja) | 2020-01-23 |
| JP2020502498A5 true JP2020502498A5 (OSRAM) | 2021-01-14 |
| JP7115756B2 JP7115756B2 (ja) | 2022-08-09 |
Family
ID=57517827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019528092A Expired - Fee Related JP7115756B2 (ja) | 2016-11-25 | 2017-11-24 | ヒトの皮膚の老化の新規バイオマーカー |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210109111A1 (OSRAM) |
| EP (1) | EP3545301A1 (OSRAM) |
| JP (1) | JP7115756B2 (OSRAM) |
| CN (1) | CN110268263B (OSRAM) |
| CA (1) | CA3041959A1 (OSRAM) |
| RU (1) | RU2019116069A (OSRAM) |
| WO (1) | WO2018096117A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020024715A2 (pt) * | 2018-06-04 | 2021-03-23 | Avon Products. Inc. | biomarcadores proteicos para identificar e tratar o envelhecimento da pele e afecções cutâneas |
| JP7633003B2 (ja) * | 2019-11-29 | 2025-02-19 | ポーラ化成工業株式会社 | 抗老化成分のスクリーニング方法 |
| WO2023090901A1 (ko) * | 2021-11-18 | 2023-05-25 | 의료법인 성광의료재단 | 기계 학습을 이용한 세포 노화의 마커를 선별하는 방법, 세포 노화 바이오 마커, 및 이를 이용한 세놀리틱 제제를 스크리닝 하는 방법 |
| WO2023133240A1 (en) * | 2022-01-07 | 2023-07-13 | Revela, Inc. | Compositions, formulations, and methods for skin treatment |
| JP2023130972A (ja) * | 2022-03-08 | 2023-09-21 | 株式会社 資生堂 | 黄ぐすみ抑制方法、黄ぐすみ抑制剤のスクリーニング方法、及び黄ぐすみ感受性の評価方法 |
| CN121208353A (zh) * | 2025-08-22 | 2025-12-26 | 北京大学第一医院(北京大学第一临床医学院) | 一种辅助诊断pcos自发性早产的蛋白质生物标志物及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001068804A2 (en) * | 2000-03-10 | 2001-09-20 | Lifespan Biosciences, Inc. | Nucleic acid sequences associated with aging, particularly skin aging |
| DE10100121A1 (de) * | 2001-01-03 | 2002-08-01 | Henkel Kgaa | Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro |
| WO2004061456A2 (de) * | 2003-01-03 | 2004-07-22 | Alcedo Biotech Gmbh | Verwendungen von hmgb, hmgn, hmga proteinen |
| WO2004083398A2 (en) * | 2003-03-17 | 2004-09-30 | The Government Of The United States Of America As Represented By The Secretary Of Department Of Health And Human Services | Therapeutic uses of hmgn1 and hmgn2 |
| US7972788B2 (en) * | 2005-08-23 | 2011-07-05 | Fancl Corporation | Skin aging marker and technique for use thereof |
| US8859021B2 (en) * | 2007-05-14 | 2014-10-14 | Sytheon | Skin appearance through gene manipulation |
| KR100999261B1 (ko) * | 2007-10-09 | 2010-12-07 | (주)아모레퍼시픽 | 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법 |
| FR2925313A1 (fr) * | 2007-12-19 | 2009-06-26 | Oreal | Utilisation cosmetique de proteines de type plakoglobine |
| US20120034613A1 (en) * | 2010-08-03 | 2012-02-09 | Nse Products, Inc. | Apparatus and Method for Testing Relationships Between Gene Expression and Physical Appearance of Skin |
| EP2704728A4 (en) * | 2011-05-03 | 2015-04-22 | Dermachip Inc | EXPRESSION SIGNATURES OF AGENTS ASSOCIATED WITH SKIN AGING AND GEN NETWORKS |
| MX2015012298A (es) * | 2013-03-15 | 2015-12-16 | Procter & Gamble | Un metodo no invasivo para medir peptidos antimicrobianos de la piel como una medicion objetica de proteccion natural de los microbios. |
-
2017
- 2017-11-24 CN CN201780072821.8A patent/CN110268263B/zh not_active Expired - Fee Related
- 2017-11-24 RU RU2019116069A patent/RU2019116069A/ru not_active Application Discontinuation
- 2017-11-24 WO PCT/EP2017/080414 patent/WO2018096117A1/en not_active Ceased
- 2017-11-24 EP EP17801484.1A patent/EP3545301A1/en not_active Withdrawn
- 2017-11-24 CA CA3041959A patent/CA3041959A1/en active Pending
- 2017-11-24 US US16/464,517 patent/US20210109111A1/en not_active Abandoned
- 2017-11-24 JP JP2019528092A patent/JP7115756B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tian et al. | Long non-coding RNA HOXA transcript antisense RNA myeloid-specific 1–HOXA1 axis downregulates the immunosuppressive activity of myeloid-derived suppressor cells in lung cancer | |
| US20240079089A1 (en) | Immunotherapy Markers And Uses Therefor | |
| RU2019116069A (ru) | Новые биомаркеры старения кожи человека | |
| JP2014521308A5 (OSRAM) | ||
| CN108701173A (zh) | 用于发现预测对检查点抑制剂敏感的msi和新表位的系统、组合物和方法 | |
| RU2012125253A (ru) | Система для увеличения экспрессии генов и вектор, содержащий указанную систему | |
| PT2716766T (pt) | Dispositivo para detectar o número de cópias de cromossomas fetais ou células tumorais | |
| KR20180091119A (ko) | 암 면역요법을 위한 치료 표적으로 환자 특이적 네오에피토프의 높은 스루풋 식별 (high-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies) | |
| CN106434928A (zh) | 一组用于肺腺癌早期诊断的circRNA标志物及其应用 | |
| JP7797199B2 (ja) | 子癇前症に特異的な循環ｒｎａシグネチャー | |
| JP2015530877A5 (OSRAM) | ||
| EP4276194A3 (en) | Methods and processes for non-invasive assessment of genetic variations | |
| JP2020524987A (ja) | 妊娠高血圧腎症に特異的な循環ｒｎａシグネチャー | |
| JP2015530868A5 (OSRAM) | ||
| JP2015210268A5 (OSRAM) | ||
| Levi et al. | p21 facilitates chronic lung inflammation via epithelial and endothelial cells | |
| Wang et al. | Activation of RAW264. 7 macrophages by active fraction of Albizia julibrissin saponin via Ca2+–ERK1/2–CREB–lncRNA pathways | |
| Renhua et al. | 165P: Long noncoding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and affects cell proliferation via regulating p21 and p57 expression | |
| JP2017528114A5 (OSRAM) | ||
| BR112020023259A2 (pt) | biomarcadores de acidente vascular cerebral no sangue | |
| CN104131113B (zh) | 一种miRNA检测试剂盒及其应用 | |
| JP2012521549A5 (OSRAM) | ||
| JP2022509018A (ja) | 放射線誘発肺障害のためのバイオマーカー及び使用方法 | |
| KR102083956B1 (ko) | 다발성 골수종 환자에서 레날리도마이드 및 덱사메타손의 치료에 대한 예후 예측용 바이오 마커 | |
| Droździk et al. | Expression of nuclear receptors (AhR, PXR, CAR) and transcription factor (Nrf2) in human parotid gland |